- All
- Product Name
- Product Keyword
- Product Model
- Product Summary
- Product Description
- Multi Field Search
 |
| Specification: | |
|---|---|
| Quantity: | |
ICA2506-9
Bioteke
The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method.
This kit is only used to monitor the 11-nor-9-tetrahydrocannabinol-9-carboxylic acid content in the urine of drug addicts. It is a non-medical device cannot treat drug addiction.It does not have clinical diagnostic significance.
This kit uses highly specific antibody drug coupling agent reaction and immunochromatographic analysis technology. The reagent contains drug conjugate coupling agent pre fixed on the membrane test region (T) and antibody conjugate on the binding pad.
During testing, drop the urine sample directly into the sampling hole of the detection card. If it is negative, the urine does not bind to the antibody conjugate on the binding pad, and the antibody conjugate on the binding pad binds to drug conjugate coupling agent, resulting in a red band in the test region. If it is positive, the drugs in the urine will react with the antibody conjugate first. When the drug content in the urine reaches a certain amount, the antibody conjugate on the binding pad will no longer bind to the specific drug coupling agent in the test region, and there will be no colored line in the test region (T).
Regardless of whether drugs are present in urine or not, a colored line will appear in the quality control region (C). The colored line displayed in the quality control region (C) is a standard for determining whether there is sufficient urine sample and whether the chromatography process is normal, and also serves as an internal control standard for the reagent.
| Product Name | Marijuana (THC) Rapid Test (Immunochromatographic Assay) |
| Model | ICA2506-9 |
| Sample | Urine |
| Storage Condition | 2~30℃（35.6~86℉） |
| Cut-off | 50 ng/ml |
| Shelf Life | 24 months |
| Classification | GPSR(EU) |
Click here to edit your content.
THC (Δ9-tetrahydrocannabinol) is the primary active ingredient in marijuana (cannabis). When smoked or orally administered, THC produces euphoric effects. The cannabinoid alters mood and sensory perceptions, impairs short term memory, and produces symptoms of anxiety, paranoia, depression, confusion, hallucination, and increased heart rate. Large doses of cannabinoid could cause the development of tolerances and physiological dependency and lead to abuse. A tolerance to the cardiac and psychotropic effects can occur and withdrawal syndrome produces restlessness, insomnia, anorexia and nausea. The main metabolite excreted in the urine is 11-nor-9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) , which are found within hours of exposure and remain detectable in the urine for 3-10 days after smoking. The Marijuana (THC) Rapid Test yields a positive result when the concentration of THC-COOH in urine exceeds detection level.
The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method.
This kit is only used to monitor the 11-nor-9-tetrahydrocannabinol-9-carboxylic acid content in the urine of drug addicts. It is a non-medical device cannot treat drug addiction.It does not have clinical diagnostic significance.
This kit uses highly specific antibody drug coupling agent reaction and immunochromatographic analysis technology. The reagent contains drug conjugate coupling agent pre fixed on the membrane test region (T) and antibody conjugate on the binding pad.
During testing, drop the urine sample directly into the sampling hole of the detection card. If it is negative, the urine does not bind to the antibody conjugate on the binding pad, and the antibody conjugate on the binding pad binds to drug conjugate coupling agent, resulting in a red band in the test region. If it is positive, the drugs in the urine will react with the antibody conjugate first. When the drug content in the urine reaches a certain amount, the antibody conjugate on the binding pad will no longer bind to the specific drug coupling agent in the test region, and there will be no colored line in the test region (T).
Regardless of whether drugs are present in urine or not, a colored line will appear in the quality control region (C). The colored line displayed in the quality control region (C) is a standard for determining whether there is sufficient urine sample and whether the chromatography process is normal, and also serves as an internal control standard for the reagent.
| Product Name | Marijuana (THC) Rapid Test (Immunochromatographic Assay) |
| Model | ICA2506-9 |
| Sample | Urine |
| Storage Condition | 2~30℃（35.6~86℉） |
| Cut-off | 50 ng/ml |
| Shelf Life | 24 months |
| Classification | GPSR(EU) |
Click here to edit your content.
THC (Δ9-tetrahydrocannabinol) is the primary active ingredient in marijuana (cannabis). When smoked or orally administered, THC produces euphoric effects. The cannabinoid alters mood and sensory perceptions, impairs short term memory, and produces symptoms of anxiety, paranoia, depression, confusion, hallucination, and increased heart rate. Large doses of cannabinoid could cause the development of tolerances and physiological dependency and lead to abuse. A tolerance to the cardiac and psychotropic effects can occur and withdrawal syndrome produces restlessness, insomnia, anorexia and nausea. The main metabolite excreted in the urine is 11-nor-9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) , which are found within hours of exposure and remain detectable in the urine for 3-10 days after smoking. The Marijuana (THC) Rapid Test yields a positive result when the concentration of THC-COOH in urine exceeds detection level.
